These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31486334)

  • 1. Pregnancy Outcomes After Human Papillomavirus Vaccination in Periconceptional Period or During Pregnancy: A Systematic Review and Meta-analysis.
    Wang A; Liu C; Wang Y; Yin A; Wu J; Zhang C; Luo M; Du L; Xiong Y; Zhao X; Huang Y
    Hum Vaccin Immunother; 2020 Mar; 16(3):581-589. PubMed ID: 31486334
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.
    Kharbanda EO; Vazquez-Benitez G; DeSilva MB; Naleway AL; Klein NP; Hechter RC; Glanz JM; Donahue JG; Jackson LA; Sheth SS; Greenberg V; Panagiotakopoulos L; Mba-Jonas A; Lipkind HS
    JAMA Netw Open; 2021 Apr; 4(4):e214340. PubMed ID: 33818618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes.
    Scheller NM; Pasternak B; Mølgaard-Nielsen D; Svanström H; Hviid A
    N Engl J Med; 2017 Mar; 376(13):1223-1233. PubMed ID: 28355499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy.
    Lipkind HS; Vazquez-Benitez G; Nordin JD; Romitti PA; Naleway AL; Klein NP; Hechter RC; Jackson ML; Hambidge SJ; Lee GM; Sukumaran L; Kharbanda EO
    Obstet Gynecol; 2017 Sep; 130(3):599-608. PubMed ID: 28796684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination.
    Zhang J; Lian Z; Xue X; Li J; Zhu Y; Huang N; Xie W
    Acta Obstet Gynecol Scand; 2024 Oct; 103(10):1943-1954. PubMed ID: 39106178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of periconceptional or pregnancy exposure of HPV vaccination and adverse pregnancy outcomes: a systematic review and meta-analysis with trial sequential analysis.
    Yan X; Li H; Song B; Huang G; Chang Q; Wang D; Yan P
    Front Pharmacol; 2023; 14():1181919. PubMed ID: 37229264
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy.
    Bukowinski AT; Hall C; Chang RN; Gumbs GR; Marie S Conlin A
    Vaccine; 2020 Aug; 38(37):5933-5939. PubMed ID: 32712082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
    Faber MT; Duun-Henriksen AK; Dehlendorff C; Tatla MK; Munk C; Kjaer SK
    Vaccine; 2019 Jan; 37(2):265-271. PubMed ID: 30503078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine: a systematic review and meta-analysis.
    Zhang Y; Zhang H; Wang B; Song G; Hayden JC; Amirthalingam P; Rahmani J; Bhagavathula AS; Li Z
    BJOG; 2020 Aug; 127(9):1066-1073. PubMed ID: 32289871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia.
    Yuill S; Egger S; Smith M; Velentzis L; Wrede CD; Bateson D; Canfell K
    J Infect Dis; 2020 Jul; 222(3):499-508. PubMed ID: 32386228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.
    Bi D; Apter D; Eriksson T; Hokkanen M; Zima J; Damaso S; Soila M; Dubin G; Lehtinen M; Struyf F
    Hum Vaccin Immunother; 2020 Jun; 16(6):1392-1403. PubMed ID: 31829767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risk of Human Papillomavirus Infection for Spontaneous Abortion, Spontaneous Preterm Birth, and Pregnancy Rate of Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis.
    Xiong YQ; Mo Y; Luo QM; Huo ST; He WQ; Chen Q
    Gynecol Obstet Invest; 2018; 83(5):417-427. PubMed ID: 29649818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.
    Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL;
    Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trial.
    Kalliala I; Eriksson T; Aro K; Hokkanen M; Lehtinen M; Gissler M; Nieminen P
    Prev Med; 2021 May; 146():106473. PubMed ID: 33639181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of the HPV Bivalent and Quadrivalent Vaccines During Pregnancy.
    Forinash AB; Yancey AM; Pitlick JM; Myles TD
    Ann Pharmacother; 2011 Feb; 45(2):258-62. PubMed ID: 21285408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9-25 years: A systematic review and meta-analysis.
    Li Y; Zhu P; Wu M; Zhang Y; Li L
    Vaccine; 2020 Jan; 38(2):119-134. PubMed ID: 31831220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.
    Setiawan D; Luttjeboer J; Pouwels KB; Wilschut JC; Postma MJ
    Jpn J Clin Oncol; 2017 Mar; 47(3):265-276. PubMed ID: 28042137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial.
    Panagiotou OA; Befano BL; Gonzalez P; Rodríguez AC; Herrero R; Schiller JT; Kreimer AR; Schiffman M; Hildesheim A; Wilcox AJ; Wacholder S;
    BMJ; 2015 Sep; 351():h4358. PubMed ID: 26346155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Maternal Human Papillomavirus Infection and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis.
    Niyibizi J; Zanré N; Mayrand MH; Trottier H
    J Infect Dis; 2020 Jun; 221(12):1925-1937. PubMed ID: 32022858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One "misunderstood" health issue: demonstrating and communicating the safety of influenza a vaccination in pregnancy: a systematic review and meta-analysis.
    Lu QC; Zhang TY; Bundhun PK; Chen C
    BMC Public Health; 2021 Apr; 21(1):703. PubMed ID: 33836695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.